Boston Scientific and Edwards settle heart valve disputes

Boston Scientific and US-based Edwards Lifesciences have agreed to settle all outstanding patent litigation between the two companies.

As part of the agreement, Edwards has made a one-time payment of $180 million to Boston Scientific, according to a joint press release issued today, January 15.

The companies had been embroiled in disputes relating to patents for heart valve replacement systems, across a number of jurisdictions.

Edwards sued Boston Scientific in August 2018, alleging that it had infringed Edwards’ patents for a method that reduces heart wall tension (US numbers 6,162,168 and 7,695,425).

Boston Scientific responded with its own patent suit in October, alleging that Edwards’ Sapien 3 transcathether heart valve infringed its patent for an “Everting heart valve” (US number 8,992,608).

All outstanding patent disputes will be dismissed, the statement said.

The rest of the settlement terms have not been made public.

Did you enjoy reading this story? Sign up to our free daily newsletters and get stories sent like this straight to your inbox.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

USPTO denies Edwards' MitraClip patent challenge

21 January 2020 The US Patent and Trademark Office has denied an inter partes review petition from Edwards Lifesciences, which argued that certain claims relating to Abbott’s MitraClip mitral valve repair device are unpatentable.

Americas

Federal Circuit resuscitates Snyder’s heart valve patent

16 October 2020 A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.

Americas

Boston Scientific secures nearly $160m in clips patents feud

13 June 2023 Win marks latest leg of cross-Atlantic litigation feud over devices that stop internal bleeding | Medical device maker garnered success against rival in the US and Germany but failed to secure an injunction in one European country.